Can-Fite BioPharma Statistics
Total Valuation
CANF has a market cap or net worth of $5.94 million. The enterprise value is -$997,714.
Important Dates
The next estimated earnings date is Thursday, March 26, 2026, before market open.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CANF has 1.32 million shares outstanding. The number of shares has increased by 87.11% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.32M |
| Shares Change (YoY) | +87.11% |
| Shares Change (QoQ) | +34.83% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 2.53% |
| Float | 2.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.61 |
| Forward PS | n/a |
| PB Ratio | 1.42 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.60 |
| Quick Ratio | 3.05 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -264.12% and return on invested capital (ROIC) is -163.99%.
| Return on Equity (ROE) | -264.12% |
| Return on Assets (ROA) | -81.86% |
| Return on Invested Capital (ROIC) | -163.99% |
| Return on Capital Employed (ROCE) | -159.54% |
| Weighted Average Cost of Capital (WACC) | 4.41% |
| Revenue Per Employee | $112,000 |
| Profits Per Employee | -$1.76M |
| Employee Count | 5 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.86% in the last 52 weeks. The beta is 0.04, so CANF's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -86.86% |
| 50-Day Moving Average | 5.24 |
| 200-Day Moving Average | 13.62 |
| Relative Strength Index (RSI) | 42.17 |
| Average Volume (20 Days) | 96,691 |
Short Selling Information
| Short Interest | 51,399 |
| Short Previous Month | 146,532 |
| Short % of Shares Out | 0.30% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.19 |
Income Statement
In the last 12 months, CANF had revenue of $560,000 and -$8.80 million in losses. Loss per share was -$8.88.
| Revenue | 560,000 |
| Gross Profit | 560,000 |
| Operating Income | -8.93M |
| Pretax Income | -8.80M |
| Net Income | -8.80M |
| EBITDA | -8.91M |
| EBIT | -8.93M |
| Loss Per Share | -$8.88 |
Full Income StatementBalance Sheet
The company has $6.46 million in cash and $90,000 in debt, with a net cash position of $6.37 million or $4.81 per share.
| Cash & Cash Equivalents | 6.46M |
| Total Debt | 90,000 |
| Net Cash | 6.37M |
| Net Cash Per Share | $4.81 |
| Equity (Book Value) | 4.18M |
| Book Value Per Share | 3.16 |
| Working Capital | 5.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.35 million and capital expenditures -$2,000, giving a free cash flow of -$8.36 million.
| Operating Cash Flow | -8.35M |
| Capital Expenditures | -2,000 |
| Free Cash Flow | -8.36M |
| FCF Per Share | -$6.32 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,595.36% |
| Pretax Margin | -1,571.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CANF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -87.11% |
| Shareholder Yield | -87.11% |
| Earnings Yield | -148.06% |
| FCF Yield | -140.59% |
Analyst Forecast
The average price target for CANF is $9,750.00, which is 237,704.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9,750.00 |
| Price Target Difference | 237,704.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 5, 2026. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jan 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
CANF has an Altman Z-Score of -31.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -31.24 |
| Piotroski F-Score | 3 |
